Agilent Technologies, Inc. $A Shares Purchased by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company raised its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 9.7% in the 2nd quarter, Holdings Channel reports. The fund owned 163,805 shares of the medical research company’s stock after acquiring an additional 14,435 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Agilent Technologies were worth $21,758,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Brighton Jones LLC grew its position in Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after buying an additional 270 shares during the last quarter. Jones Financial Companies Lllp raised its position in Agilent Technologies by 15.9% during the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after buying an additional 769 shares during the last quarter. Geneos Wealth Management Inc. raised its position in Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after buying an additional 212 shares during the last quarter. Acadian Asset Management LLC lifted its stake in shares of Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after acquiring an additional 758 shares during the period. Finally, Sivia Capital Partners LLC acquired a new stake in shares of Agilent Technologies in the 2nd quarter worth $273,000.

Insider Transactions at Agilent Technologies

In other news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the sale, the director directly owned 4,924 shares in the company, valued at approximately $745,395.12. This trade represents a 11.41% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on A. Jefferies Financial Group started coverage on shares of Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price target on the stock. Citigroup raised their price objective on shares of Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Thursday, August 27th. HSBC lowered their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. JPMorgan Chase & Co. boosted their target price on Agilent Technologies from $180.00 to $190.00 and gave the stock an “overweight” rating in a research report on Thursday, August 27th. Finally, TD Cowen increased their target price on Agilent Technologies from $155.00 to $180.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $170.33.

Agilent Technologies Stock Performance

NYSE:A opened at $146.91 on Friday. The firm’s fifty day simple moving average is $143.71 and its 200-day simple moving average is $128.62. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The stock has a market cap of $41.42 billion, a PE ratio of 28.92, a price-to-earnings-growth ratio of 2.24 and a beta of 1.24. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $163.75.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts expect that Agilent Technologies, Inc. will post 6.2 earnings per share for the current fiscal year.

Agilent Technologies Company Profile

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.